CATALYST FINANCIAL PARTNERS LLC
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1927537
BOSTON, MA
Position in TMO
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$1,139,089
+$36,588 QoQ
Shares Held
2,272
+1.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#1,384
of 2,606 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CATALYST FINANCIAL PARTNERS LLC holds $2,429,052 across 4 Diagnostics & Research names. TMO ranks #1 (46.9% of the industry book) .
All Filings in TMO
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,139,089 | 2,272 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $1,102,501 | 2,243 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,281,163 | 2,211 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $893,406 | 1,842 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $705,905 | 1,741 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $956,387 | 1,922 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $962,425 | 1,850 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $1,182,087 | 1,911 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $1,058,442 | 1,914 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $1,045,015 | 1,798 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $865,718 | 1,631 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $769,884 | 1,521 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $449,748 | 862 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $455,332 | 790 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $388,787 | 706 | Shares | Sole | 2023-01-19 | |
| No filing history on record for this holder in this stock. | ||||||